ImmunityBio, Inc. (IBRX) NASDAQ
8.12
+0.415(+5.39%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.12
+0.415(+5.39%)
Currency In USD
| Market Cap | 1.82B |
| Enterprise Value | 2.61B |
| P/E Ratio | -22.86 |
| PEG Ratio | -4.57 |
| Price/Sales Ratio | 73.65 |
| Price/Book Ratio | -16.08 |
| Enterprise/Revenue | 80.62 |
| Enterprise/EBITDA | -40.85 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -3.1 |
| Operating Margin | -2.26 |
| Return On Assets | -0.7 |
| Return On Equity | 0.64 |
| Revenue | 113.29M |
| Revenue/Share | 0.11 |
| Gross Profit | 112.54M |
| EBITDA | -223.56M |
| Net Income | -351.4M |
| Diluted EPS | -0.38 |
| Total Cash | 242.82M |
| Total Cash/Share | 0.25 |
| Total Debt | 878.12M |
| Total Debt/Equity | -1.76 |
| Current Ratio | 5.1 |
| Book Value Per Share | -0.5 |
| 52-Week Change | 223.31 |
| 52-Week High | 12.43 |
| 52-Week Low | 1.83 |
| Moving Average 50 Days | 7.97 |
| Moving Average 200 Days | 4.06 |
| Average Volume | 31.97M |
| Shares Outstanding | 1.03B |
| % Held by Institutions | 17.85 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |